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Abstract Increased susceptibility to infections, partic-
ularly respiratory viral infections, is a hallmark of
advancing age. The underlying mechanisms are not
well understood, and there is a scarcity of information
regardingthe contributionofthe innateimmunesystem,
which is the first line of defense against infections. In
the present study, we have investigated the effect of
advancing age on plasmacytoid dendritic cell (PDC)
function because they are critical in generating a robust
antiviral response via the secretion of interferons (IFN).
Our results indicate that PDCs from the aged are
impaired in their capacity to secrete IFN-I in response
to influenza virus and CPG stimulation. Additionally,
we observed a severe reduction in the production of
IFN-III, which plays an important role in defense
against viral infections at respiratory mucosal surfaces.
Thisreduction inIFN-I andIFN-III werea resultofage-
associated impaired phosphorylation of transcription
factor, IRF-7. Furthermore, aged PDCs were observed
to be impaired in their capacity to induce perforin and
granzyme in CD8 T cells. Comparison of the antigen-
presenting capacity of aged PDC with young PDC
revealed that PDCs from aged subjects display reduced
capacity to induce proliferation and IFN-gamma secre-
tion in CD4 and CD8 T cells as compared with PDCs
from young subjects. In summary, our study demon-
strates that advancing age has a profound effect on PDC
function at multiple levels and may therefore, be
responsible for the increased susceptibility to infections
in the elderly.
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Introduction
Aging is characterized by an increased susceptibility to
infectious diseases as the ability to fight new infections
decreases, and latent infections re-emerge and increase
in severity. Infections, such as influenza, pneumonia,
and respiratory syncytial virus (RSV) (Powers 1994;
Treanor and Falsey 1999; Gavazzi et al. 2004), thus
account for nearly one third of deaths in the aged
population (Groen et al. 1998; Schildgen 2009).
Alterations in the adaptive immune system, particularly
the T cells, are thought to account for these age-related
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subjects exhibit significantly lower CD8+ cytotoxic
responses to influenza virus when compared with
young subjects (Mbawuike et al. 1990, 1993;P o w e r s
and Belshe 1993; Christensen et al. 2000;E f f r o se ta l .
2003;Y a n ge ta l .2005; Jiang et al. 2009). Further-
more, IFN-γ secretion from both CD4 and CD8 Tcells
also decreases with age (Powers and Belshe 1993;
Castle et al. 1997;K a n ge ta l .2004). Although the
decline in Tcell immunity is considered a key factor in
the increased susceptibility to infections in the elderly,
the impact of aging on the innate immune system is
not well understood (Pawelec et al. 1998; Solana et al.
2006). Since the innate immune system plays a crucial
role in controlling pathogen invasion, and in instruct-
ing the adaptive immune system to initiate an antigen-
specific response, it is important to determine the
extent to which aging affects the innate immune
responses.
Plasmacytoid dendritic cells (PDCs) are innate
immune cells that are key players in the establishment
of an effective immune response against invading
pathogens, particularly viruses. PDCs are present in
the peripheral blood (0.2–0.5%) and secondary
lymphoid organs and express the IL-3 receptor
(CD123). They are characterized by their plasma
cell-like morphology, low phagocytic capacity, and
copious production of type I IFNs in response to viral,
bacterial, and parasitic infections (Cella et al. 2000;
Liu 2005). A single cell is able to produce 1–2I Uo f
IFN in response to viral stimulus, an amount that is
10–100 times more than most other cells. PDCs owe
their ability to detect and respond to microbes to a
specific repertoire of Toll-like receptors (TLRs),
TLR7 and TLR9 (Takeuchi et al. 2004; Ito et al.
2005; Seeds et al. 2006), which are located in the
endosomes and recognize certain nucleotide motifs in
viral and bacterial RNA and DNA (Hemmi et al.
2003; Diebold et al. 2004;H e i le ta l .2004),
respectively. TLR9 recognizes unmethylated 2′-deox-
yribo (cytidine–phosphate–guanosine) (CpG) DNA
motifs (Hemmi et al. 2000) that are present at high
frequencies in pathogens such as viruses and bacteria
but are rare in vertebrates. TLR7 recognizes viral
single-stranded RNA (ssRNA; influenza) and imida-
zaquinolones (Hemmi et al. 2002). Unlike other
receptors, TLR7 and TLR9 can sense inactivated
viruses and thus do not require infection of PDC by
viruses to be activated. This is beneficial, as many
viruses have developed mechanisms to block the
production of type I IFNs early after infection. PDCs
constitutively express high levels of the transcription
factor IRF-7, which allows rapid production of IFNs
in response to infections (Honda et al. 2005). IFNs are
considered the first line of defense against pathogens
because of their ability to orchestrate numerous
biological and cellular processes. Type I IFNs
enhance the cytotoxic activity of natural killer and
CD8 T cells (Biron 1998; Stetson and Medzhitov
2006; Fitzgerald-Bocarsly and Feng 2007) and regu-
late the secretion of IFN-γ by both CD8 and CD4 T
cells (Biron 1998, 2001;O ’Shea and Visconti 2000;
Stetson and Medzhitov 2006).
Recent studies have reported that PDCs also produce
type III IFNs (IL28/29 or IFN λ) in response to viruses
(Coccia et al. 2004). Studies of the molecular events
leading to type III IFN (IFN-III) production suggest a
common mechanism with IFN-I (Ank et al. 2006;
Onoguchi et al. 2007). IFN-III signal through a receptor
complex composed of a unique IFN-λR1 chain in
addition to a shared IL-10R2 chain, which is also the
second subunit of the IL-10, IL-22, and IL-26 receptor
complexes (Kotenko et al. 2003). However, whereas
IFN-I receptors are expressed in most cell types, IFN-
λR1 demonstrates a more restricted pattern of expres-
sion, limiting the response of IFN-III to primarily
epithelium-like tissues (Witte et al. 2009; Khaitov et
al. 2009; Mordstein et al. 2010). Using mice lacking
functional receptors for type I IFN, type III IFN, or
both, it was observed that IFN-III plays an important
role in the defense against several human pathogens that
infect the respiratory tract, such as influenza A virus,
respiratory syncytial virus, and SARS Coronavirus
(Mordstein et al. 2010). Many studies (Shodell and
Siegal 2002; Stout-Delgado et al. 2008;J i n ge ta l .2009;
Canaday et al. 2010; Panda et al. 2010) document
impairment in the secretion of IFN-I by PDCs from
aged subjects in response to viruses. Nevertheless, there
is a scarcity of information on the status of IFN-III
secretion by PDCs from aged subjects. Age-related
alterations in IFN-III secretion may therefore be of great
relevance since infection of soft or mucosal tissues are
most common in the elderly.
Besides secretion of antimicrobial cytokines, acti-
vation of PDCs by TLR7/9 ligands also leads to
upregulation of co-stimulatory as well as MHC class I
and class II molecules on the PDCs. Upon maturation,
PDCs lose their capacity to produce IFNs, acquire a
364 AGE (2011) 33:363–376myeloid DC-like morphology and initiate adaptive
immune responses leading to CD4 and CD8 T cell
activation (Gibson et al. 2002). There is no published
data regarding the effect of age on the antigen-
presenting function of PDCs. Age-associated impair-
ment or reduction in PDC antigen presenting function
may also contribute to the increased susceptibility to
viral and bacterial infections in the elderly.
In the present study, we report age-associated
perturbations in PDC function at three levels: first,
at the level of induction of IFN-I and IFN-III via viral
and TLR stimulation; secondly, at the level of
induction of cytoxicity in CD8 T cell; and finally, at
the level of antigen presentation or priming and
proliferation of CD4 and CD8 T cells.
Materials and methods
Blood donors
Blood was collected from healthy aged (65–90 years)
and young (20–35 years) donors. Aged subjects were
of middle-class socio-economic status and were living
independently. Cohort description is provided in
Table 1. The Institutional Review Board of the
University of California, Irvine, approved this study.
Isolation and purification of PDCs
Peripheral Blood Mononuclear Cells were separated
from the blood using Ficoll density gradient centrifu-
gation. PDCs were then positively selected using
BDCA-4 PDC purification kit from Miltenyi Biotech.
This kit contains magnetic beads coupled to BDCA-4,
which is expressed exclusively on PDCs. We routinely
recovered approximately 0.5–1×10
5 PDCs from 40 ml
blood. Purity of the PDC population was >90%.
Stimulation of PDCs
PDCs 2×10
4 from aged and young subjects were
stimulated with either 10 μg/ml heat-inactivated
influenza virus A/PR/8/34-INF (Charles River, North
Franklin, CT), or with 50 μg/ml CPG2395 (Coley
Pharmaceuticals, Wellesley, MA). The RNA from the
influenza is a TLR7 ligand, and the synthetic
unmethylated oligonucleotide of CPG2395 is a
TLR9 ligand. After overnight stimulation at 37°C,
PDCs were centrifuged, and the supernatants were
collected and stored at −70°C for cytokine measure-
ment by multiplex cytokine assay (Millipore, San
Jose, CA). IFN-III (IL-29) in the supernatants was
measured using specific ELISA kit (PBL Biomedi-
cals, Piscataway, NJ).
Flow cytometry staining of PDCs and TLRs
Two hundred microliters of whole blood was incu-
bated with CD303-(BDCA-2) APC, and CD123 PE
antibodies for 20 min at room temperature (RT) to
stain for PDCs. RBCs were lysed using BD FACS
lysing Solution (BD Biosciences) and fixed with 2%
PFA. The cells were subsequently permeabilized for
30 min at RT using the BD perm buffer. TLR7 and
TLR9 antibodies (Imgenex, SanDiego, CA) were
added and the stained PDCs were acquired after
washing. Flow jo (Treestar Inc.) was used to analyze
gated CD303- and CD123-positive cells.
Polymerase chain reaction (PCR)
Purified PDCs from six aged and six young subjects
were pooled, and RNAwas extracted using Tri Reagent
kit (Molecular Research Center Inc., Cincinnati, OH,
USA), following the manufacturer"s protocol. Real time
PCR was performed with the Mx3005P QPCR System
instrument (Stratagene) using the TaqMan Gene
expression assay with a FAM™ dye-labeled TaqMan®
MGBprobe and two polymerase chain reaction PCR
primers (Applied Biosystems). Briefly, 1 ug of total
RNAs were reverse-transcribed using the RT-PCR kit
(Applied Biosystems), following the manufacturer"s
Table 1 Description of the aged and young cohorts
Young, n=25 Aged, n=25
Age (range) 25 (20–35) 80 (65–89)
Gender, female 15 (60%) 18 (72%)
Comorbidities
Arthritis 0 14 (56%)
Hypertension 0 9(36%)
Dyslipidemia 0 11 (44%)
Diabetes 0 0
Medications
Vitamins 0 19 (76%)
Antioxidants 0 14 (56%)
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and the Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) gene was used for normalization.
Phospho IRF-7 staining
PBMCs from aged and young donors were stimulated
with CPG or influenza for 30 min at 37°C. Cells were
then fixed with 2% PFA for 10 min at RT, and
subsequently incubated with CD303-(BDCA-2) APC
(Miltenyi Biotech) and CD123 PE (BD Biosciences,
San Jose, CA) antibodies for 20 min at RT to stain for
PDC surface markers. After washing, PDCs were
permeabilized with phospho perm buffer I (BD
Biosciences) and stained with phospho IRF-7-
ALEXA 488 (BD Biosciences) for 30 min at RT.
Mouse IgG1-Alexa 488 (BD Biosciences) was used
as isotype control. Stained PDCs were acquired on
FACsCalibur and gated CD123 plus CD303 double-
positive PDCs were analyzed for phospho IRF-7
using Flow jo.
Perforin and granzyme induction in CD8 T cells
PDCs were purified from PBMCs from aged and
young donors, as described in Fig. 1. CD8 T cells
from young donors (to rule out any Tcell defect) were
purified via magnetic beads using negative selection
(Stem Cell Sep). PDCs 1×10
4 were cultured together
with 1×10
5 CD8 T cells in 96-well plates, and the
Fig. 1 PDCs from aged
subjects are impaired in
their capacity to secrete
IFN-I and IFN-III. Purified
PDCs from aged and young
subjects were stimulated
with CPG or heat-killed
influenza (Flu). Cytokine
secretion was determined
after overnight stimulation.
a Bar diagram depicts the
level of type I IFN secretion
by aged and young PDCs. b
Bar diagram depicts the
level of type III IFN secre-
tion by aged and young
PDCs. c Bar diagrams de-
pict the levels of TNF-α,
IL-6, IL-10, and IP-10 se-
cretion by aged and young
PDCs. Figure is mean ±SE
of 25 different aged and
young subjects
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described concentrations. Five days later, supernatant
was collected, and the cells were surface-stained for
CD8. After fixing and permeabilizing, the cells were
stained with perforin and granzyme antibodies (BD
biosciences), and appropriate isotype controls were
used. Flow jo was used to analyze gated CD8 T cells
for presence of these granules. Supernatant collected
earlier was assayed for IFN-γ secretion from CD8 T
cells using specific ELISA kit (BD Biosciences).
CD4 and CD8 T cell proliferation
PDCs were purified from PBMCs of aged and young
donors and stimulated with CPG and influenza, as
described. After overnight stimulation, supernatants
were collected and stored at −20°C for cytokine
estimation using the multiplex cytokine assay (Milli-
pore). Stimulated PDCs were cultured with purified,
CFSE-labeled allogeneic Tcells from young donors at
a ratio of 1:20. Six days after culture, cells were
collected and stained for CD4 and CD8 markers.
Proliferation of gated CD4 T and CD8 T cells was
determined by measuring the dilution of CFSE dye.
Supernatant collected was assayed for secretion of
IFN-γ and IL-10 by specific ELISA.
Statistical analysis
Statistical analysis was performed by a statistician.
Within-group differences between unstimulated and
stimulated conditions were tested using paired t tests.
Mann Whitney or Wilcoxon signed-rank test was
used to measure significance between aged and young
groups. Values of p<0.05 were considered significant.
Results
PDCs from aged subjects are impaired in their ability
to secrete IFN-I and IFN-III (IL-29) following
stimulation with CPG and influenza virus
Secretion of IFNs by PDCs is critical in fighting
microbial infections. Reports from the literature suggest
that PDCs from aged secrete less IFN-α as compared
with PDCs from young subjects. Various mechanisms
such as reduced numbers of PDCs have been suggested
as the culprit. We have previously reported that the
percent of PDCs is comparable in the blood of aged and
young subjects (Agrawal et al. 2007). To further
confirm that reduced IFN secretion is not a conse-
quence of reduction in numbers of PDC with age, in
the present study, we have compared IFN secretion
from equal numbers of purified aged and young PDCs.
Subjects are described in Table 1. The control
population included 25 individuals in the age range of
20–35 years with an average age of 25 years. The
geriatric population consisted of 25 individuals in the
age range of 65–89 years with an average age of
80 years. The younger individuals were healthy and
not on medications.
As shown in Fig. 1a, secretion of IFN-I in response
to CPG (Ag~1,057 pg/ml, Yg~1,584 pg/ml, p=
0.048) and influenza (Ag~1163 pg/ml, Yg~
1941 pg/ml, p=0.032) was significantly impaired in
PDCs from the elderly when compared with PDCs
from the young. Recent reports suggest that secretion
of IFN-III or IL-28/29 by PDCs also plays an
important role in fighting microbial infections, partic-
ularly at mucosal surfaces (Coccia et al. 2004;
Mordstein et al. 2010). Since IFN-III induction
requires similar signals as IFN-I (Ank et al. 2006;
Onoguchi et al. 2007), we determined if there was
also an age-associated reduction in IFN-III secretion
(Fig. 1b). We observed a highly significant reduction
in the levels of IFN-III secretion by aged PDCs in
response to influenza (Ag~350 pg/ml, Yg~908 pg/ml,
p=0.017) as compared with young subjects. The level
of IFN-III reduction in the aged was more pronounced
than the age-related decrease observed for IFN-I. In
contrast to influenza, CPG induced low levels of IFN-
III. Although CPG stimulation showed reduced IFN-III
production by aged PDCs compared with young
PDCs, the difference was not significant (Ag~
125 pg/ml, Yg~200 pg/ml, p=0.19).
A multiplex assay for a panel of other cytokines
and chemokines was also performed. IL-6, IL-10,
TNF-α, and IP-10 were detected after stimulation of
PDCs with CPG and influenza. However, there were
no significant differences (p>0.05) in the secretion of
these cytokines and chemokines between the aged and
young PDCs (Fig. 1c). These data demonstrate that
PDCs from aged subjects show a selective impair-
ment in their ability to secrete IFN-I and IFN-III in
response to influenza virus. Since the impairment of
cytokine secretion by aged PDCs is restricted to IFNs
it suggests that the uptake of ligands by the TLRs is
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secretion may be a consequence of age-associated
alterations in the signaling pathway responsible for
production of IFN-I and IFN-III.
In the aged subjects, there were several subgroups
based on comorbidities. For some of the subgroups,
we had enough subjects to do a subgroup analysis.
Arthritis was the most common comorbid condition in
the aged population studied. IFN-I and IFN-III levels
were comparable between arthritis-positive and
arthritis-negative subjects (p=0.78 IFN-I, p=0.44
IFN-III). Aged subjects with hypertension and dysli-
pidemia were also not different in their induction of
IFN-I and IFN-III (p>0.8). Many of the aged subjects
were also taking vitamins and antioxidants; however,
we did not observe any difference in IFN levels
between the two groups (p>0.9). Based on these
subgroup analyses, we feel fairly confident that the
comparisons between the young control and aged
subject populations are yielding valid results across a
general geriatric group.
The expression of TLRs is comparable between aged
and young subjects
Although our results in Fig. 1 suggested that reduced
IFN secretion by aged PDC might not be a conse-
quence of reduced TLR expression, we nevertheless
compared the expression of TLR7 and TLR9 in PDCs
from aged and young subjects to completely rule out
this possibility. As shown in Fig. 2a, b, there was no
significant difference (p>0.05) in the expression of
either TLR7 or TLR9 in PDCs from aged and young
subjects. These data suggest that age-associated
alterations in signaling events downstream of TLRs
may account for the reduced IFN secretion by PDCs.
PDCs from aged subjects exhibit reduced
phosphorylation of IRF-7 in response to CPG
and influenza virus
Activation of TLR7 or TLR9 in PDCs leads to
MyD88 activation and subsequent recruitment of
TRAF6 (TNF receptor associated factor 6), IRAK-4
(interleukin-1 receptor-associated kinase 4), IRAK-1
(interleukin-1 receptor-associated kinase 1), and IRF-
7 (interferon regulatory factor-7; Kawai et al. 2004;
Honda et al. 2004). IRAK-4 phosphorylates IRAK-1,
which in turn phosphorylates IRF-7. Once phosphor-
ylated by IRAK-1, IRF-7 translocates to the nucleus
and initiates transcription of genes encoding IFN-I
and IFN-III. The formation of the IRF-7, IRAK-1,
and MyD88 complex is thus essential for IFN-I and
IFN-III production. To investigate whether reduced
IFN secretion by aged PDCs is due to a reduced
expression of any of these signaling and adaptor
molecules, we determined the level of expression of
IRF-7, MyD88, and IRAK-1 between aged and young
PDCs using real-time (RT) PCR. As shown in Fig. 3a,
IRF-7, MyD88, and IRAK-1 gene expression levels
are comparable between aged and young subjects,
suggesting that the decrease in the expression of these
genes is not responsible for the reduced IFN-I and
IFN-III secretion in the aged.
It has been observed that type I IFN receptor
(IFNAR) deficient PDCs fail to produce type I IFNs in
response to TLR agonists, and that IFNAR signaling
itself further augments IFN-I production in a positive
feedback loop (Watarai et al. 2008). Therefore, we
investigated if the expression of IFNAR1, and two
Fig. 2 The expression of TLR7 and TLR9 in PDCs are
comparable between aged and young subjects. Intracellular
expression of TLRs 7 and 9 was determined by flow cytometry.
a Bar diagram depicts the mean fluorescence intensities (MFI)
of TLR7 in aged and young PDCs. b Bar diagram depicts the
mean fluorescence intensities (MFI) of TLR9 in aged and
young PDCs. Figure is mean ±SE of 12 different aged and
young subjects
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expression levels of both the IFNAR receptors were
comparable in PDCs from aged and young subjects
(Fig. 3a), suggesting that signaling through IFNARs
may not be responsible for the reduced IFN production
by PDCs from aged subjects.
Since the activation and phosphorylation of the
transcription factor IRF-7 is essential for the secretion
of IFN-I and IFN-III by PDCs, we examined the
phosphorylation of IRF-7 in PDCs from aged and
young subjects after stimulation with CPG or influ-
enza virus. Both CPG and influenza resulted in
significantly increased (p=0.002 for CPG, p=0.001
for influenza) IRF-7 phosphorylation compared with
unstimulated controls (Fig. 3b, c) in young subjects.
In the aged PDCs, the phosphorylation of IRF-7 was
severely impaired (Fig. 3b, c). Stimulation with
influenza resulted in significantly increased (p=0.01)
phosphorylation of IRF-7 in aged PDCs. Stimulation
with CPG resulted in an even lower IRF-7 phosphor-
ylation and there was no significant (p>0.05) upre-
gulation compared with unstimulated controls. These
results clearly demonstrate that the PDCs from the
aged subjects are impaired in their ability to phos-
phorylate IRF-7, which may be responsible for the
reduced IFN-I and IFN-III production.
Fig. 3 Phosphorylation of
IRF-7 is impaired in PDCs
from aged subjects. a Bar
diagram depicts the ratio of
IRAK-1, MyD88, IRF-7,
IFNAR1, and IFNAR2 to
GAPDH in PDCs from aged
and young as determined by
real-time PCR. b Histo-
grams denote the phosphor-
ylation of IRF-7 at 30 min
in unstimulated and CPG
and influenza (Flu)-stimu-
lated aged and young PDCs.
Figure is representative of
12 similar experiments. Sol-
id grey histograms depict
the isotype; black lined his-
togram is the experimental
group. c Bar graph depicts
the mean fluorescence in-
tensity (MFI) minus the
isotype MFI of Phospho
IRF-7 30 min post-
stimulation with CPG and
influenza. Figure is mean
±SE of 12 different aged
and young subjects
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capacity to induce perforin, granzyme and IFN-γ
producing CD8 T cells
Activation of PDCs by viruses is considered a key
event in enhancing the cytotoxicity of CD8 T cells by
inducing cytotoxic granules of perforin and gran-
zyme, predominantly through IFN-I and IFN-III
secretion (Tiwari et al. 1991; Kolumam et al. 2005).
Since IFN-I and IFN-III production is decreased in
aged PDCs, we investigated if the decrease was
sufficient to impair the generation of cytotoxic CD8
T cells. As shown in Fig. 4a, c (contour plots),
influenza-stimulated young and aged PDCs resulted
in an increased percentage of CD8 T cells expressing
perforin and granzyme relative to the unstimulated
PDCs. However, the percent of CD8 T cells express-
ing perforin and granzyme over unstimulated controls
was significantly less (p=0.035 for perforin, p=0.005
for granzyme) in aged PDCs as compared with that in
young PDCs (Fig. 4b, d). Stimulation of aged PDCs
with CPG did not result in a significant increase (p>
0.05) in the percentage of CD8 T cells expressing
perforin and granzyme over unstimulated controls.
However, CPG stimulation of young PDCs showed a
significant increase (p<0.05, Fig. 4a, c)i nt h e
percentage of perforin and granzyme expressing
CD8 T cells. Therefore, percent of CD8 T cells
expressing perforin and granzyme over unstimulated
controls was significantly less (p=0.049 for perforin,
p=0.015 for granzyme) in aged PDCs as compared
with that in young PDCs (Fig. 4b, d).
In addition to perforin and granzyme, IFN-γ
production by CD8 T cells is also essential for
mounting a robust antiviral response. Therefore, we
used ELISA to assay the IFN-γ released by the CD8
T cells after exposure to the stimulated young and
aged PDCs. IFN-γ secretion displayed a profile very
similar to perforin and granzyme (Fig. 4e, f).
Figure 4e depicts the level of IFN-γ secreted by
CD8 T cells while Fig. 4f represents the fold increase
which is derived by calculating the increase in IFN-γ
secretion on stimulation over the unstimulated values.
IFN-γ secretion was significantly reduced (p=0.01)
in CD8 T cells co-cultured with influenza-stimulated
aged PDCs relative to influenza-stimulated young
PDCs. IFN-γ secretion in response to CPG was also
significantly impaired (p=0.026) in the aged subjects
relative to the young subjects. These data demonstrate
that PDCs from aged are impaired in their capacity to
enhance the expansion of cytotoxic CD8 T cells
expressing perforin, granzyme, and IFN-γ.
PDCs from aged subjects are impaired in their
capacity to prime CD4 and CD8 T cells
In addition to secretion of IFNs, activation of PDCs
by microbial ligands also leads to antigen presen-
tation (Gibson et al. 2002). After initial secretion of
IFNs, PDCs subsequently mature, and lose their
capacity to produce IFNs and acquire antigen
presenting functions. Mature PDCs are capable of
priming adaptive immune CD4 and CD8 T cell
responses. We investigated the capacity of aged and
young PDCs to induce CD4 T and CD8 T cell
proliferation. Purified aged and young PDCs were
stimulated overnight with CPG or influenza virus as
described. Next day, the cells were collected and
cultured with purified T cells to determine T cell
proliferation, and cytokine secretion. Although
influenza-stimulated aged PDCs induced CD4 and
CD8 T cell proliferation, the proliferation was
significantly (p=0.027 for CD4 T, p=0.032 for
CD8 T) reduced when compared with young subjects
(Fig. 5d). CPG-stimulated aged PDCs were unable to
induce proliferation of CD4 T cells above the
unstimulated controls. Induction of CD8 T cell
proliferation by CPG-stimulated aged PDCs was
slightly enhanced over controls though the difference
was not significant (p>0.05). In contrast, CPG-
stimulated PDCs from young donors significantly
(p<0.05) enhanced the proliferation of CD4 T cells
a n dC D 8Tc e l l s .T h eC D 4a n dC D 8Tc e l l
proliferation induced by aged and young PDCs was
comparable in the absence of stimulation.
Next, we determined the nature of cytokines
secreted by T cells primed with stimulated and
unstimulated aged and young PDCs. T cells stimulat-
ed with both CPG and flu stimulated aged PDCs
displayed higher levels of IL-10 and lower levels of
IFN-γ compared with T cells primed with their young
counterparts though the differences are not significant
(p>0.05). IL-5 levels were undetectable (data not
shown).
These data suggest that PDCs from aged subjects
display reduced capacity to prime T cell proliferation
and cytokine secretion and are therefore defective in
antigen presentation.
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Immunosenescence compromises protection against
pathogens and contributes to mortality and morbidity
in the elderly. The scarcity of information about the
mechanisms involved in age-associated immune
dysfunction makes it difficult to develop effective
treatments to boost innate immunity in the elderly. In
Fig. 4 PDCs from aged are impaired in their capacity to prime
cytotoxic CD8 T lymphocyte responses. a Contour plot depicts
the intracellular expression of perforin in CD8 T cells co-
cultured with aged and young PDCs stimulated with CPG and
influenza (Flu). Figure is representative of 15 such experiments.
b Graph depicts the fold induction of perforin in CD8 T cells
cultured with CPG or influenza-stimulated aged and young
PDCs compared with unstimulated PDCs. Figure is mean ±SE
of 15 different aged and young subjects. Each dot corresponds
to one separate subject. c Contour plot depicts the intracellular
expression of granzyme in CD8 T cells co-cultured with aged
and young PDCs stimulated with CPG and influenza (Flu).
Figure is representative of 15 such experiments. d Graph
depicts the fold induction of granzyme in CD8 T cells cultured
with CPG or influenza stimulated aged and young PDCs
compared with unstimulated PDCs. Figure is mean ±SE of 15
different aged and young subjects. Each dot corresponds to one
separate subject. e Graph depicts the levels of IFN-γ in the
supernatant of aged and young PDC-CD8 coculture on
stimulation with CPG and influenza (Flu). f Graph depicts the
fold induction of IFN-γ in CD8 T cells cultured with CPG or
influenza-stimulated aged and young PDCs compared with
unstimulated PDCs. Figure is mean ±SE of 15 different aged
and young subjects. Each dot corresponds to one separate
subject
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with age, and the effect of this decline results in
reduced T lymphocyte responses associated with
aging.
Aged subjects display increased susceptibility to
viral infections particularly of the respiratory mucosa
(Powers 1994; Groen et al. 1998; Treanor and Falsey
1999; Gavazzi et al. 2004; Schildgen 2009). PDCs are
critical in mounting an effective immune response
against viruses because of their ability to secrete very
high levels of IFNs (Liu 2005). Here, we demonstrate
that purified PDCs from aged subjects secrete reduced
quantities of IFN-I after stimulation with CPG and
influenza virus relative to their young counterparts.
This finding is consistent with numerous other studies
that reported a decline in IFN-I production by PDCs
from aged subjects in response to CPG and influenza
in humans and mice (Shodell and Siegal 2002; Stout-
Delgado et al. 2008; Jing et al. 2009; Canaday et al.
2010; Panda et al. 2010). Furthermore, we report a
more pronounced decline in the production of IFN-III
by aged PDCs in response to influenza. IFN-III is a
recently discovered antiviral cytokine that has a
similar activity as IFN-I except that its action is
restricted to renal and mucosal epithelial surfaces
(Dumoutier et al. 2004; Ank et al. 2006; Onoguchi et
al. 2007; Sommereyns et al. 2008; Khaitov et al.
2009; Li et al. 2009; Mordstein et al. 2010). The IFN-
III system is believed to have been evolved as a
specific protection of epithelia and to prevent viral
invasion through skin and mucosal surfaces. In a
model for a localized Herpes Simplex Virus 2 (HSV-2)
Fig. 5 PDCs from aged are
impaired in their capacity
to prime CD4 and CD8 T
cell responses. a Bar graph
depicts the percentage of
CD4 T cells proliferating
after culture with CPG and
influenza stimulated aged
and young PDCs. b Bar
graph depicts the fold in-
duction of proliferation in
CD4 T cells cultured with
CPG or influenza-stimulated
aged and young PDCs
compared with unstimulated
PDCs. c Bar graph depicts
the percentage of CD8 T
cells proliferating after cul-
ture with CPG and
influenza-stimulated aged
and young PDCs. d Bar
graph depicts the fold in-
duction of proliferation in
CD8 T cells cultured with
CPG or influenza stimulated
aged and young PDCs
compared with unstimulated
PDCs. e Bar graph depicts
the level of IFN-γ secreted
by T cells. f Bar graph
depicts the level of IL-10
secreted by T cells Figure is
mean ±SE of 12 different
aged and young subjects
372 AGE (2011) 33:363–376infection, it was observed that IFN-III completely
blocked viral replication in the vaginal mucosa and
prevented development of disease. This is in contrast
to IFN-I, which had a more modest antiviral activity
(Ank et al. 2006). IFN-III displayed moderate antiviral
activity against systemic HSV-2 infection emphasizing
its role in protection from microorganisms at mucosal
surfaces. More recently, Mordstein et al. (Mordstein et
al. 2010) observed that IFN-I and IFN-III receptor
double-knockout mice showed enhanced susceptibility
to various viruses that primarily replicate in lung
epithelial cells such as influenza, RSV and SARS-
Coronavirus. In contrast, they observed that IFN-III
did not provide protection against intra-nasal infection
with lassa virus. It was suggested this was because the
expression of functional IFN-III receptors in the lung
was restricted to epithelial cells. Our observation of a
severe age-associated decline in the production of IFN-
III may explain the increased risk of influenza and
other respiratory infections in the elderly. It may also
be important in defense against other infections such as
those of skin and urinary tract that are prevalent in the
elderly. The role of IFN-III has not been previously
explored in aging. In contrast to influenza, we did not
observe a significant age-associated reduction in IFN-
III in response to CPG. This could be due to low levels
of induction of IFN-IIIs by CPG. Reports indicate that
IFN-III is induced after stimulation with several
ssRNA viruses, whereas the information on viruses
with other genomes (DNA and double-stranded RNA
[dsRNA]) and bacteria is sparse (Brand et al. 2005;
Ank et al. 2006).
We consistently found CPG to be much less
stimulatory than flu in all our experiments. The
response in aged PDCs was even lower than what
was observed with young PDCs. It may be one of the
factors responsible for the increased susceptibility of
the aged to bacterial infections such as pneumonia.
However, this finding needs to be confirmed further
using whole bacteria since it is possible that purified
oligo-dinucleotides such as CPG are not taken up by
PDCs as efficiently as a whole virus or bacteria.
Various mechanisms, such as decreased numbers
of PDC (Shodell and Siegal 2002; Jing et al. 2009;
Canaday et al. 2010), and decreased expression of
TLR7 and TLR9 (Jing et al. 2009; Panda et al. 2010),
have been suggested for the observed decrease in type
I IFN production by aged humans. Contrary to these
reports, our observations suggest that decreased IFN-I
and IFN-III secretion by aged PDCs is due to an
impaired phosphorylation of IRF-7, a key transcrip-
tion factor responsible for the production of IFNs
(Honda et al. 2004). Since PDCs constitutively
express high levels of IRF-7 (Fitzgerald-Bocarsly
and Feng 2007), activation via TLRs causes the
phosphorylation of IRF-7 by IRAK-1. The phosphor-
ylated IRF-7 translocates to nucleus to induce
transcription of IFN-I. IFN-III induction in PDCs
has also been observed to utilize a similar mechanism
(Ank et al. 2006;O n o g u c h ie ta l .2007). Age-
associated declines in the activation of IRF-7 have
been shown to be responsible for the decreased IFN-α
(IFN-I) secretion in PDCs in mice (Stout-Delgado et
al. 2008). Further evidence that reduced expression of
the TLR7 and 9 is not responsible for the decline in
IFN production with age comes from the fact that
aged PDCs display normal secretion of inflammatory
cytokines (IL-6, IL-10, TNF-α) and chemokines (IP-
10) after TLR stimulation, suggesting that the age-
related defects in cytokine production may be limited
to defective IFN signaling pathways.
In addition to reduced IFN secretion, we also
observed a severe decline in the induction of perforin,
granzyme, and IFN-γ production in CD8+ T cells
cultured with influenza and CPG-stimulated aged
PDCs relative to young PDCs. Reduced IFN-I
secretion by aged PDCs may account for this
decrease. Several studies have demonstrated that
IFN-I plays an essential role in the differentiation
and function of effector CD8 T lymphocytes.
Kolumam et al. (2005) found that CD8 T cells
lacking the type I IFN receptor were profoundly
impaired in their ability to expand and differentiate
into effector CTLs after LCMV infection, demonstrat-
ing that type I IFNs provide a non-redundant
costimulatory signal in vivo. Similar to IFN-I, IFN-
III can be induced by viral infections and has been
observed to have potent antiviral activity against viral
infections in vivo (Bartlett et al. 2005; Ank et al.
2006, 2008; Almeida et al. 2008). Several reports
have now demonstrated that IFN-III has the ability to
inhibit the replication of a number of viruses,
including hepatitis C virus (Robek et al. 2005). IFN-
III has also been shown to provide protection in mice
from genital herpes infection and disease progression
(Ank et al. 2006, 2008; Iversen et al. 2010). Type III
IFNs are capable of inducing the expression by cells
infected with virus of many antiviral proteins, such as
AGE (2011) 33:363–376 373dsRNA-activated serine/threonine protein kinase,
2′,5′-OAS, and MxA (also known as MX1) proteins,
which mediate antiviral protection (Brand et al. 2005;
Ank et al. 2006). However, whether IFN-III has a
direct effect on CD8 cytotoxicity is not clear at
present.
PDC are able to differentiate into mature dendritic
cells, upon viral stimulation and stimulate allogeneic
naïve CD4 T lymphocytes (Cella et al. 2000;
Kawamura et al. 2006). Recently, it was shown that
not only viruses, but also whole live bacteria can
induce PDC activation, resulting in Th1 polarization
of naive CD4 T cells (Guiducci et al. 2006). Reduced
function of T cells such as decreased proliferation and
decline in IFN-γ production are believed to be major
mechanisms of increased susceptibility to viral infec-
tions in the elderly. The efficiency of PDC as antigen-
presenting cells has not been characterized in aging.
Our data demonstrate that the PDC"s ability to present
antigens is severely compromised with age. Aged
PDCs are impaired in their ability to induce CD4 and
CD8 T cell proliferation and IFN-γ secretion (Fig. 5).
This suggests that aberrant PDC functions can
adversely affect the adaptive immune response in
older individuals.
In summary, we demonstrate that advancing age
significantly affects the functions of PDCs at all levels
from secretion of antiviral cytokines to priming of T
cell responses. Therefore, the age-associated decline
in PDC function may be a major factor responsible
for the increased susceptibility of elderly individuals
to infections. Delineating this functional decline may
help in designing optimal therapies to treat infections
in the elderly. For example, our findings suggest that
administration of type III IFNs may be a novel
approach to treating of respiratory viral infections in
adults, particularly because the restricted expression
of the IFN-III receptor will result in fewer side effects.
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